(Q36055997)

11 August 2017

1 reference

title

Preventing transmission: plant-derived microbicides and mucosal vaccines for reproductive health (English)

1 reference

11 August 2017

Kevin J Whaley

1

1 reference

11 August 2017

Larry Zeitlin

series ordinal

2

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 March 2005

1 reference

11 August 2017

1 reference

11 August 2017

volume

23

1 reference

11 August 2017

issue

15

1 reference

11 August 2017

page(s)

1819-1822

1 reference

Monoclonal antibodies for reproductive health: Part I. Preventing sexual transmission of disease and pregnancy with topically applied antibodies

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.012

Using monoclonal antibodies to prevent mucosal transmission of epidemic infectious diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.012

A humanized monoclonal antibody produced in transgenic plants for immunoprotection of the vagina against genital herpes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.012

Preventing sexual transmission of HSV and HIV: the challenge for active and passive immunization of mucosal surfaces

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.012

Rectal immunization for induction of specific antibody in the genital tract of women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.012

Mucosal vaccination strategies for women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.012

Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.012

Polymeric controlled delivery for immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.012

HIV-1 neutralizing antibodies: how full is the bottle?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.012

Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.012

Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.012

Cellular immunity elicited by human immunodeficiency virus type 1/ simian immunodeficiency virus DNA vaccination does not augment the sterile protection afforded by passive infusion of neutralizing antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.012

Tests of vaginal microbicides in the mouse genital herpes model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.012

Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.012

Public health. A sound rationale needed for phase III HIV-1 vaccine trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.012

A phase I comparative study of three contraceptive vaginal films containing nonoxynol-9. Postcoital testing and colposcopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.012

Can needle-free administration of vaccines become the norm in global immunization?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.012

10.1016/J.VACCINE.2004.11.012

7 January 2021

Identifiers

DOI

1 reference

11 August 2017

1 reference